Prognosis

Sinovac’s South Africa Partner Plans Local Shots by Year-End

Numolux says it could make 100 million shots per year
Production to include shots beyond Covid-19 doses, COO says

The Pandemic in the Next 6 Months

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Antony Sguazzin and Janice Kew

September 16, 2021 at 7:00 AM UTC

Updated on

September 16, 2021 at 10:37 AM UTC

This article is for subscribers only.

Sign up to our Next Africa newsletter and follow Bloomberg Africa on Twitter

Sinovac Biotech Ltd.’s South African partner plans to have a vaccine-making facility operational as early as the end of the year after the two companies started a Covid-19 inoculation trial in infants, children and adolescents.